Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Growth Rate of the Antibiotic Resistance Market from 2024 to 2033?
In recent times, there has been significant growth in the market size for antibiotic resistance. The market, which is projected to increase from $11.43 billion in 2023 to $12.13 billion in 2024, will do so at a compound annual growth rate (CAGR) of 6.1%. Factors that have contributed to this growth during the past period include the absence of new antibiotics, improper and excessive usage of antimicrobials in humans, animals, and plants, extreme contamination of waste effluents, lowered rates of vaccinations, and an absence of diagnostic tools.
The market size for antibiotic resistance is predicted to steadily escalate in upcoming years. The projection is that it will reach a value of $15.47 billion by 2028, with a compound annual growth rate (CAGR) of 6.3%. The anticipated expansion during this time can be linked to factors such as incomplete treatment programs, global travel, insufficient infection prevention measures, self-prescribing of medication, transmission between species, and high population concentrations. Significant trends projected for this period encompass advancements in drug delivery technology, international collaborations for monitoring, the increasing influence of artificial intelligence, and a rise in innovative therapies.
Claim Your Free Sample of the Global Antibiotic Resistance Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12131&type=smp
What Key Factors Are Fueling the Growth of the antibiotic resistance Market?
The rise in drug-resistant infections is projected to boost the growth of the antibiotic-resistance market in the future. These infections are the result of resistant bacteria, which can make curing the infection extremely challenging or even unattainable. Drugs developed to counter antimicrobial resistance offer treatment for different drug-resistant infections, contributing to the enhancement of antibiotic treatment results pertaining to both the primary and secondary pathogens. This effectiveness is contingent on the specifics of resistance mechanisms and the interaction structure of the microbiome community. For example, as reported by the European Centre for Disease Prevention and Control in November 2022, a public health agency of the European Union based in Sweden, approximately 35,000 people succumb to antimicrobial-resistant diseases every year within the EU/EEA. Furthermore, infections related to Klebsiella pneumoniae escalated by 20% back in 2021, and Candida auris reported cases nearly doubled from 2020 to 2021. Consequently, the rise in drug-resistant infections is propelling the growth of the antibiotic-resistance market.
What Are the Major Segments of the Antibiotic Resistance Market?
1) By Drug Class: Beta Lactum Antibiotic, Cephalosporins, Quinolones Antibiotics, Macrolide Antibiotics, Tetracyclines, Oxazolidinones, Other Drug Classes
2) By Pathogen: Staphylococcus aureus, Staphylococcus pneumonia, Neisseria gonorrhoeae, Enterococcus Faecium, Escherichia coli, Klebsiella pneumonia, Shigella, Clostridium difficile, Other pathogens
3) By Disease Type: Urinary tract infection, Intra-abdominal infection, Blood stream infections, Clostridium difficile infections, Other Disease Types
4) By Mechanism of Action: Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Other Mechanism Of Actions
5) By End Users: Hospitals, Homecare, Specialty clinics, Other End-users
What New Trends Are Transforming the Antibiotic Resistance Market?
The antibiotic resistance market is witnessing a major trend where product innovations are taking center stage. The primary objective of dominant companies in this market is to fortify their market standing through the introduction of cutting-edge products. For example, Alkem Laboratories Limited, a pharmaceutical enterprise based in India, in January 2023 launched Zidavi, an innovative antibiotic, for treating multi-drug resistant (MDR) infections. The aim is to ensure the drug is readily available, affordable, and accessible, hence, aiding in saving the lives of seriously ill patients. Zidavi, a distinctive blend of ceftazidime and avibactam is capable of treating infections triggered by MDR gram-negative pathogens. This drug comes in a sterile powdered concentrate for reconstitution, each single-dose vial containing ceftazidime pentahydrate equivalent to 2 g ceftazidime and avibactam sodium equivalent to 0.5 g avibactam. It is an effective substitute for treating hospital-acquired pneumonia (HAP) and severe intra-abdominal infections (IAIs) caused by meropenem and colistin.
Order Now for Fast Delivery of Your Antibiotic Resistance Market Report!
https://www.thebusinessresearchcompany.com/report/antibiotic-resistance-global-market-report
Which Regions Are Driving Growth in the Antibiotic Resistance Market?
North America was the largest region in the antibiotic resistance market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibiotic resistance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Antibiotic Resistance Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the antibiotic resistance market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Antibiotic Resistance Market Include
1. Antibiotic Resistance Market Executive Summary
2. Antibiotic Resistance Market Segments
3. Antibiotic Resistance Market Size And Template Market Growth Rate
4. Key Antibiotic Resistance Market Trends
5. Major Antibiotic Resistance Market Drivers
……
25. Key Mergers And Acquisitions In The Antibiotic Resistance Market
26. Top Antibiotic Resistance Companies
27. Antibiotic Resistance Market Opportunities And Strategies
28. Antibiotic Resistance Market, Conclusions And Recommendations
29. Appendix
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
